BioCentury
ARTICLE | Clinical News

BPX01: Phase IIa started

March 14, 2016 7:00 AM UTC

BioPharmX began a double-blind, placebo-controlled Phase IIa trial of topical BPX-01 in about 30-35 patients. ...